Drug Type Small molecule drug |
Synonyms 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine, Blavin, Flotrin + [47] |
Target |
Action antagonists |
Mechanism α1A-AR antagonists(Alpha-1a adrenergic receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (07 Aug 1987), |
Regulation- |
Molecular FormulaC19H30ClN5O6 |
InChIKeyNZMOFYDMGFQZLS-UHFFFAOYSA-N |
CAS Registry70024-40-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00610 | Terazosin Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Essential Hypertension | Japan | 31 Mar 1989 | |
Hypertension, Renal | Japan | 31 Mar 1989 | |
Hypertension | United States | 07 Aug 1987 | |
Prostatic Hyperplasia | United States | 07 Aug 1987 |
FDA_CDER Manual | Not Applicable | - | Placebo (Study 1) | jpcjhejuyk(ngtaubvacw) = ulgevgdllk wzfvtklhhl (qejigpecqq ) View more | Positive | 29 Jul 2024 | |
(Study 1) | jpcjhejuyk(ngtaubvacw) = iqfyxjmmhq wzfvtklhhl (qejigpecqq ) View more | ||||||
FDA_CDER Manual | Not Applicable | - | kiuzdojwtr(ylgozdvxme) = vbhjivjyjf wkpzqqzrka (brzsflgemt ) View more | Positive | 29 Jul 2024 | ||
Placebo | kiuzdojwtr(ylgozdvxme) = iegmldubmj wkpzqqzrka (brzsflgemt ) View more | ||||||
Phase 2/3 | 104 | Placebo (Placebo) | bliejytngr(gvmgsikems) = boutfzixwb xnplqinuwv (lowascbwac, 7.84) View more | - | 02 Mar 2015 | ||
(Terazosin) | bliejytngr(gvmgsikems) = ckqnpxbvyc xnplqinuwv (lowascbwac, 6.03) View more | ||||||
Not Applicable | 733 | fpvdihkmid(vvmpokrwcl) = enntlvyfbi wssfmyhuoj (ugjrleuxsd ) View more | - | 01 May 2008 | |||
dqigsngxas(zyvnzsrhiu) = ftsnwyybyj rssslslelk (vfifalhzsj ) |